‘Immunotherapy’ the new cancer treatment buzzword
Harnessing a patient’s immune system to recognize and destroy tumour cells has been the central goal in the past few years of anti-cancer immunotherapy trials. There has been considerable interest in Adopted Cell Transfer, (ACT), where tumour-specific cytotoxic T cells are infused into cancer patients. These recognise, target and destroy cancer cells. ACT is proving…
Details